Caboxib (Cabozantinib) 20mg/80mg | Multi-Kinase Inhibitor | Ziska Pharmaceuticals Ltd. | GLT

REQUEST A QUOTE

Tap "Request a Quote" to open WhatsApp — the product details are already filled in. Just add your quantity and destination country.

  • We reply within 24 hours with pricing, availability & COA
  • Serves individuals and institutions worldwide

Prefer email? [email protected] · +86 15234153837

Share
Product description

Caboxib is a generic cabozantinib manufactured by Ziska Pharmaceuticals in Bangladesh. This listing offers both standard capsule strengths — 20 mg in packs of 90 and 80 mg in packs of 30 — covering the complete range needed for the two principal dosing regimens of this multi-kinase inhibitor.

Generic Information: Caboxib (Cabozantinib)

Ziska Pharmaceuticals Ltd. is an established Bangladeshi manufacturer with a growing oncology portfolio and regional export reach. Caboxib is its cabozantinib brand, containing the same active ingredient as the originator Cometriq and Cabometyx. The availability of both the 20 mg and 80 mg strengths in one listing makes it convenient for clinics managing different indications.

What Is Caboxib (Cabozantinib) Used For?

Caboxib is used to treat medullary thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, differentiated thyroid cancer and neuroendocrine tumors. The 20 mg and 80 mg capsules are combined to reach the dose appropriate for each condition.

How Does Caboxib Work?

Cabozantinib inhibits several receptor tyrosine kinases — chiefly MET, VEGFR-2 and RET, along with AXL, KIT and FLT-3. This multi-target action suppresses tumor proliferation, starves tumors of new blood vessels and limits metastasis. Caboxib delivers the same mechanism as the originator.

Indications

  • Progressive, metastatic medullary thyroid cancer
  • Advanced renal cell carcinoma
  • Hepatocellular carcinoma after sorafenib
  • Differentiated thyroid cancer refractory to radioactive iodine
  • Well-differentiated neuroendocrine tumors

Dosage & Administration

For medullary thyroid cancer, the dose is 140 mg once daily, made up from 80 mg and 20 mg capsules. For renal cell carcinoma, hepatocellular carcinoma, differentiated thyroid cancer and neuroendocrine tumors, the dose is 60 mg once daily. Both strengths in this listing support these regimens. Swallow capsules whole.

Side Effects

Diarrhea, fatigue, nausea, decreased appetite, hand-foot skin reaction and hypertension are common. Serious risks include severe bleeding, gastrointestinal perforation, blood clots, heart problems and osteonecrosis of the jaw. Monitoring of blood pressure and liver function is required.

Storage & Handling

Store at room temperature in the original packaging, protected from moisture and light, out of children's reach, and not past expiry.

Why Choose Caboxib?

  • Both strengths available — 20 mg and 80 mg in one listing.
  • Ziska Pharmaceuticals — an established Bangladeshi oncology manufacturer.
  • Affordable — lower-cost cabozantinib for multiple cancer indications.

How to Order Caboxib from GLT

  1. Contact GLT via WhatsApp +86 15234153837 or email [email protected].
  2. Receive a quotation and delivery estimate.
  3. Pay via Hao Yi Lian / 好易联.
  4. Dispatch with documentation and tracking.

A valid prescription may be requested before dispatch. Institutions and individual patients are served.

FAQ

1. What strengths does Caboxib come in?

Caboxib is available as 20 mg and 80 mg capsules in this listing.

2. Who manufactures Caboxib?

Caboxib is manufactured by Ziska Pharmaceuticals Ltd. in Bangladesh.

3. Do I need a prescription?

Yes, cabozantinib is prescription-only.

Related Oncology Products

XinKePing 欣可平 (Avatrombopag) 20mg*10 Tablets | Nanjing Hencer China | GLT

XinKePing — API-plus-tablet integrated avatrombopag from Nanjing Hencer Pharmaceutical (Jemcare group), China Mainland

Orforglipron (OriYo) 0.8–17.2mg Tablets | Bangladesh Generic Oral GLP-1 | GLT

National Drug Co. generic orforglipron, 6-dose titration for weight management

KeZeRui 科瑞泽 (Avatrombopag) 20mg*10 Tablets | Sichuan Kelun China | GLT

KeZeRui — national-procurement avatrombopag from Sichuan Kelun Pharmaceutical, China's integrated API + tablet maker

SPINRAZA (Nusinersen) 12mg/5mL | Buy from China | SMA Therapy | GLT

Biogen's first-in-class antisense oligonucleotide for SMA, NMPA-approved and nationally reimbursed in China — buy from...

Mounjaro KwikPen (Tirzepatide) 10–60mg/2.4mL Multi-Dose | Eli Lilly USA | GLT

Mounjaro KwikPen — Eli Lilly single-patient multi-dose pen, six US strengths (10–60mg/2.4mL, 4 doses each)...

Tirzema (Tirzepatide) 2.5/5/7.5mg/0.5mL Single-Dose Pen | Incepta Bangladesh | GLT

Tirzema — Incepta Pharmaceuticals tirzepatide single-dose pen, three official strengths (2.5/5/7.5mg/0.5mL) for T2DM and weight...

Orforglipron (LuciOrfor) 0.8–17.2mg Tablets | Laos Generic Oral GLP-1 | GLT

Lucius Pharmaceuticals (Laos) generic orforglipron, 6-dose titration for weight management

AVATODX (Avatrombopag) 20mg*30 Tablets | Bigbear Pharmaceutical Laos | GLT

AVATODX — avatrombopag 20mg by Bigbear Pharmaceutical (Lao) Co., Ltd., Lao Reg. 06L0985/23, 30-tablet bottle